ロード中...
Genome Editing Gene Therapy for Duchenne Muscular Dystrophy
Duchenne muscular dystrophy (DMD) is a severe genetic disorder caused by loss of function of the dystrophin gene on the X chromosome. Gene augmentation of dystrophin is challenging due to the large size of the dystrophin cDNA. Emerging genome editing technologies, such as TALEN and CRISPR-Cas9 syste...
保存先:
| 出版年: | J Neuromuscul Dis |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
IOS Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5240599/ https://ncbi.nlm.nih.gov/pubmed/27858753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JND-150116 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|